Skip to main content
Premium Trial:

Request an Annual Quote

RXi Licenses shRNAi Technology From Cold Spring Harbor Lab

NEW YORK (GenomeWeb News) – CytRx subsidiary RXi Pharmaceuticals has licensed short hairpin RNAi technology from Cold Spring Harbor Laboratory, CytRX said today.
 
Under the licensing agreement, RXi purchased a worldwide, non-exclusive license to the technology, which was developed by Cold Spring Harbor’s Gregory Hannon.
 
Hannon is a co-founder and member of RXi’s scientific advisory board.
 
Financial terms of the agreement were not released.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.